
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.523 | 0.575 | -8.785 | 7.211 | 17.127 | -16.89 | -2.27 | -0.287 |
Return on Equity (%) | 0.583 | 0.595 | -9.007 | 7.432 | 18.026 | -17.67 | -2.342 | -0.301 |
Return on Invested Capital (%) | -39.1 | -31.114 | -90.914 | -19.984 | -27.166 | 720.217 | 931.872 | 1837.037 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 43.044 | 42.988 | 39.76 | 43.087 | 51.756 | 42.026 | 41.031 | 39.826 |
Earnings Per Share | 0.266 | 0.301 | -4.613 | 3 | 8.844 | -8.612 | -0.927 | -0.128 |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | -1.442 | 0.016 | -0.698 | -1.787 | 0.057 | 0.09 | 0.028 | 0.04 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 0.545 | 0.606 | -4.251 | 3.259 | 9.105 | -8.014 | -0.398 | 0.511 |
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,55M | 7,8M | 5,35M | 5,65M | 5,25M | 4,9M | 5,4M | 4,9M |
Fin d'année 30 Juin 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 217,76M |
Ratio cours/bénéfice | -347,11 |
Ratio prix/ventes | 55,13 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 1,12 |
Rendement de dividende | 138,80% |
Actions en circulation | 4,9M |
Volume moyen (1 semaine) | 22,52k |
Volume moyen (1 mois) | 28,58k |
Variation sur 52 semaines | -0,80% |
Plus haut sur 52 semaines | 48,76 |
Plus bas sur 52 semaines | 38,88 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales